SageFusion
  • Research access
  • Firms
  • Insights
  • Podcast
  • The Wealth Almanac
  • About
  • Contact Us
  • Login
Home›Firms›Data licensing
Data licensing for firms

Stock research data that shows what failed

Most vendor data ships without its out-of-sample checks or its failures. SageFusion licenses nightly research outputs together with the research log, so a buyer can see which studies held up, which showed no edge, and which were withdrawn.

Request a sample Read the research log

Key points

  • For funds, research teams and data buyers
  • Evening shortlist, labels, log and test history
  • Limits stated up front
  • Rules, weights and thresholds stay private

The buyer's problem

When a data vendor shows a signal, the question that matters is what else was tried. Without the failed versions and the out-of-sample checks, there is no way to tell a real effect from the best of many tries.

SageFusion's research data is built the other way round: every result arrives with its label and its history, and the failures are in the log next to the successes.

What firms can license

Coverage spans stocks, ETFs, options, futures, crypto and spot FX. The licensable outputs include:

  • Evening shortlist: produced after each close, every evening, from a nightly scan of nearly 4,000 US-listed stocks and ETFs.
  • Result labels: how each result held up.
  • Research log: every tested idea, including the ones that failed, and why.
  • Test history: what was tested, the dates, and how it held up on unseen data.
VerifiedVerified (no edge)Failed / retracted

How each label is earned

  • Score studies are built on 2005 to 2015 data and must hold up on 2016 to 2026, after trading costs.
  • Nightly picks and breakout setups are each compared with a random stock on the same night.
  • When many versions of an idea are tried, the best one is discounted for the number of tries.
  • Tests use the date data was actually recorded and available.

The method is explained in plain words in our guide to testing a signal against random.

Known limits, stated up front

Most studies use today's listed stocks, so companies that disappeared are missing. That is survivorship bias, and each affected study says so. The research log also shows retractions, such as a machine-learning study withdrawn for a look-ahead bug. A buyer sees these before licensing, not after. See the trading ideas that failed.

Who it is for

The data is built for funds, quant and research teams, data vendors and other data buyers who need to know how a result was tested before it reaches their own process. It suits teams that want to check the work themselves: compare the outputs with their own universe, rerun their own baselines, and read the failures alongside the results.

It is research data for evaluation and research. It is not investment advice and not a managed product.

Delivery and terms

Format, frequency and coverage are agreed per licence, for example file delivery or API. Samples are shared after a short review of each request. See what a research data sample contains.

What is never shared: the rules, weights, thresholds and formulas behind the research. Firms license the outputs, labels and test history.

FAQ

Common questions

What do Verified, Verified (no edge) and Failed / retracted mean?

Verified means a study held up on later, unseen data; it does not mean the idea will make money. Verified (no edge) means it was tested cleanly and found no usable effect. Failed / retracted means it did not hold up or was withdrawn, with the reason kept next to it.

How is the data delivered?

Format, frequency and coverage are agreed per licence, for example file delivery or API. Samples are shared after a short review of each request, so your team can check the outputs, labels and test history before agreeing terms. Request a sample through the form on the Firms page.

Is the history free of survivorship bias?

No. Most studies use today's listed stocks, so companies that disappeared are missing, which tends to flatter long-only results. Each affected study says so next to the result. We state this before licensing so your team can judge the data with the limit in view.

Keep reading

Related pages

What is in a research data sample

What a sample contains, how to judge it, and what stays private.

Read more

We publish the trading ideas that failed

Why the research log keeps every failure, with the reason.

Read more

How to tell if a trading signal is just luck

The placebo test: compare a signal with random picks traded the same way.

Read more
For research teams

Request a sample.

Tell us a little about your firm. We review each request and reply by email.

Request a sample Read the research log

Research tool, not investment advice. Studies use daily prices of today's listed stocks unless stated. Legal disclosure

SageFusion

by Investment Science LLC

Product

  • Firms
  • Research access
  • Insights
  • Podcast
  • The Wealth Almanac

Company

  • About
  • Contact
  • Sign in
  • Legal
  • Privacy

Learn

  • How we test
  • Evening shortlist
  • Research log
  • Congress trades
  • Data licensing

Contact

[email protected]

+1 (917) 512-9523

99 Wall Street Suite 1672, New York, NY 10005

Schedule a meeting

SageFusion is a research product of Investment Science LLC. Content on this website is for information only and is not investment advice, a recommendation, or an offer to buy or sell any security. Research results are historical, can be affected by data limitations (including survivorship bias), and do not guarantee future results. Investing involves risk, including possible loss of principal. Legal disclosure

© 2026 SageFusion® · Investment Science LLC · Research tool, not investment advice.

  • Research access
  • Firms
  • Insights
  • Podcast
  • The Wealth Almanac
  • About
  • Contact Us
  • Login